Guardant Health Inc revenue for the last year amounted to 9.58 B MXN, the most of which — 8.73 B MXN — came from its highest performing source at the moment, Precision Oncology Testing, the year earlier bringing 7.65 B MXN. The greatest contribution to the revenue figure was made by United States — last year it brought Guardant Health Inc 8.94 B MXN, and the year before that — 8.20 B MXN.